Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letters to the Editor
  • Published:

CCR2 chemokine receptor and AIDS progression

Nature Medicine volume 3, pages 1052–1053 (1997)Cite this article

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Smith, M. et al. Contrasting genetic influence of CCR2 and CCR5 receptor gene variants on HIV-1 infection and disease progression. Science 277, 959–965 (1997).

    Article  CAS  Google Scholar 

  2. Michael, N. et al. The role of CCR5-Δ32 and CCR2B-64I polymorphisms in HIV-1 transmission and disease progression. Nature Med. 3, 1160–1162 (1997).

    Article  CAS  Google Scholar 

  3. Dean, M. et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CCR5 structural gene. Science 273, 1856–1862 (1996)

    Article  CAS  Google Scholar 

  4. Micheal, N. et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med. 3, 338–340 (1997).

    Article  Google Scholar 

  5. Bacchetti, P. & Moss, A.R. Incubation period of AIDS in San Francisco. Nature 338, 251–253 (1989).

    Article  CAS  Google Scholar 

  6. Mahoney, E.M. & Orav, E.J. A missing data approach to parameter estimation in multistage disease models for doubly-censored failure times. Doctoral Thesis, Harvard School of Public Health, 1993.

  7. Kroner, B.L., Rosenberg, P.S., Aledort, L.M., Alvord, W.G. & Goedert, J.J. for the Multicenter Hemophilia Cohort Study. HIV-1 infection incidence among persons with hemophilia in the Unived States and Western Europe 1978-1990. J. Acquir. Immune. Defic. Syndr. 7, 279–286 (1994).

    CAS  PubMed  Google Scholar 

  8. Munoz, A. et al. Estimation of time since exposure for a precedent cohort. STAT Med. 11, 939–952 (1992).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Science Applications International Corp. Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland, 21702-1201, USA

    Michael W. Smith, Mary Carrington, Cheryl Winkler & Deborah Lomb

  2. Laboratory of Genomic Diversity National Cancer Institute-FCRDC Frederick, Maryland, 21702-1201, USA

    Michael Dean, Gavin Huttley & Stephen O'brien

Authors
  1. Michael W. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary Carrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cheryl Winkler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deborah Lomb
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gavin Huttley
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephen O'brien
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, M., Carrington, M., Winkler, C. et al. CCR2 chemokine receptor and AIDS progression. Nat Med 3, 1052–1053 (1997). https://doi.org/10.1038/nm1097-1052c

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1097-1052c

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing